Related Experiment Video
Updated: Jun 17, 2026
11:13
Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
Published on: June 9, 2023
DeltaEF1 promotes breast cancer cell proliferation through down-regulating p21 expression.
1Medical College of Nankai University, Tianjin, China.
Biochimica Et Biophysica Acta
|December 17, 2009
Summary
The transcription factor deltaEF1 promotes breast cancer cell proliferation by advancing the cell cycle. It down-regulates p21 while up-regulating CDK2 and CDK4, driving G1-S transition.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Cycle Regulation
Background:
- The transcription factor deltaEF1 is implicated in cell proliferation and differentiation.
- Its precise role in regulating the cell cycle, particularly in breast cancer, remains unclear.
Purpose of the Study:
- To elucidate the role of deltaEF1 in breast cancer cell cycle progression.
- To investigate the molecular mechanisms by which deltaEF1 influences cell proliferation.
Main Methods:
- Ectopic expression and RNA interference (RNAi) of deltaEF1 in MDA-MB-231 breast cancer cells.
- Cell cycle analysis (flow cytometry) to assess phase distribution.
- Quantitative analysis of cell cycle regulatory proteins (p21, CDK2, CDK4) via Western blotting or similar techniques.
- Analysis of p21 promoter activity and deltaEF1 binding using techniques like ChIP or reporter assays.
- Correlation analysis of deltaEF1 and p21 expression in cell lines and clinical samples.
Main Results:
- Ectopic deltaEF1 expression in MDA-MB-231 cells increased S-phase population, promoting proliferation.
- deltaEF1 knockdown via RNAi led to cell cycle arrest, indicating a role in G1-S transition.
- deltaEF1 down-regulated p21 expression and up-regulated CDK2 and CDK4.
- deltaEF1 directly inhibited p21 transcription by binding to its promoter's E(2) box.
- An inverse correlation between deltaEF1 and p21 levels was observed in breast cancer cell lines and patient tumors.
Conclusions:
- deltaEF1 plays a significant role in promoting breast cancer cell proliferation by regulating cell cycle progression.
- deltaEF1 exerts its proliferative effect by down-regulating the cell cycle inhibitor p21 and up-regulating cyclins/CDKs.
- These findings highlight deltaEF1 as a potential therapeutic target in breast cancer.
More Related Videos
Related Concept Videos
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:23Negative Regulator Molecules
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
01:19Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:54Canonical Wnt Signaling Pathway
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...